Back
Slate Grocery REIT Vs. Kymera Therapeutics, Inc. Industry Stock Comparison
Buy
53
SGR.UN.TO
Slate Grocery REIT
Last Price:
$14.95
Seasonality Move:
1.82%
Buy
87
KYMR
Kymera Therapeutics, Inc.
Last Price:
$89.98
Seasonality Move:
7.7%
Buy
53
Slate Grocery REIT (SGR.UN.TO)
is a Buy
Is Slate Grocery REIT a Buy, Sell or Hold?
-
The current Slate Grocery REIT [SGR.UN.TO] share price is $14.87. The Score for SGR.UN.TO is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
-
SGR.UN.TO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
87
Kymera Therapeutics, Inc. (KYMR)
is a Buy
Is Kymera Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Kymera Therapeutics, Inc. [KYMR] share price is $86.88. The Score for KYMR is 87, which is 74% above its historic median score of 50, and infers lower risk than normal.
-
KYMR is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
SGR.UN.TO Stock Price Chart
What is Slate Grocery REIT's stock price today?
-
The Slate Grocery REIT share price today is $14.87Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SGR.UN.TO is experiencing selling pressure, which indicates risk of future bearish movement.
KYMR Stock Price Chart
What is Kymera Therapeutics, Inc.'s stock price today?
-
The Kymera Therapeutics, Inc. share price today is $86.88Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing slight selling pressure.
SGR.UN.TO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0 | Buy |
| Relative Strength Index (14 RSI): | 48.75 | Sell |
| Chaikin Money Flow: | -49746 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (14.79 - 15.11) | Sell |
| Bollinger Bands (100): | (14.27 - 14.93) | Buy |
KYMR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.97 | Buy |
| Relative Strength Index (14 RSI): | 72.81 | Buy |
| Chaikin Money Flow: | -897315 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (58.72 - 73.96) | Buy |
| Bollinger Bands (100): | (43.27 - 64.19) | Buy |
SGR.UN.TO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 14.89 | Sell |
| 20-day SMA: | 14.98 | Sell |
| 50-day SMA: | 14.83 | Buy |
| 200-day SMA: | 14.43 | Buy |
| 8-day EMA: | 14.88 | Sell |
| 20-day EMA: | 14.92 | Sell |
| 50-day EMA: | 14.83 | Buy |
| 200-day EMA: | 14.4 | Buy |
KYMR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 72.38 | Buy |
| 20-day SMA: | 67.89 | Buy |
| 50-day SMA: | 62.54 | Buy |
| 200-day SMA: | 44.51 | Buy |
| 8-day EMA: | 75.59 | Buy |
| 20-day EMA: | 69.41 | Buy |
| 50-day EMA: | 62.91 | Buy |
| 200-day EMA: | 49.79 | Buy |
Slate Grocery REIT Earnings Growth & SGR.UN.TO Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Kymera Therapeutics, Inc. Earnings Growth & KYMR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.63 per share, and a decrease next year of $0.36 per share.
Slate Grocery REIT Technical Analysis
| Nov 26 | Nov 27 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 26 | 27 | 28 | 01 | 02 | 03 | 04 | 05 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Kymera Therapeutics, Inc. Technical Analysis
| Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 25 | 26 | 28 | 01 | 02 | 03 | 04 | 05 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||